ASHLEY HOUSE: Open Payments
NPI 1013254358 · GULFPORT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,519 in 127 payments from 24 companies in 2025. Trend: 2023 $3,065 · 2024 $2,718 · 2025 $2,519
Food & beverage: $2,519
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 11 | $304 |
| Novo Nordisk Inc | 18 | $269 |
| Medtronic, Inc. | 12 | $257 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $210 |
| Dexcom, Inc. | 12 | $203 |
| Lilly USA, LLC | 11 | $198 |
| Amgen Inc. | 9 | $196 |
| Xeris Pharmaceuticals, Inc. | 9 | $145 |
| Corcept Therapeutics | 8 | $136 |
| Radius Health, Inc. | 3 | $75 |
Products named: FREESTYLE LIBRE, MINIMED 780G, Kerendia, Ozempic, Dexcom G6 Transmitter, EVENITY, JARDIANCE, Korlym.
Industry payments across MS — which companies pay providers there.
